Skip to main content
InterCure Ltd. (TLV:INCR)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
259.10
-9.30 (-3.46%)
Mar 9, 2026, 5:24 PM IDT

InterCure Revenue

InterCure had revenue of 130.01M ILS in the half year ending June 30, 2025, a decrease of -37.68%. This brings the company's revenue in the last twelve months to 243.12M, down -10.84% year-over-year. In the year 2024, InterCure had annual revenue of 238.85M, down -32.82%.

Revenue (ttm)
243.12M
Revenue Growth
-10.84%
P/S Ratio
0.58
Revenue / Employee
759.76K
Employees
320
Market Cap
141.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024238.85M-116.71M-32.82%
Dec 31, 2023355.55M-33.13M-8.52%
Dec 31, 2022388.68M169.01M76.93%
Dec 31, 2021219.68M154.64M237.78%
Dec 31, 202065.04M56.11M628.60%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 55.02B
Danel (Adir Yeoshua) 2.87B
Kamada 578.74M
BrainsWay 162.56M
Geffen Residence & Renewal 84.00K
Epitomee Medical 37.17M
Golden House 46.05M
Rekah Pharmaceutical Industry 300.24M
Revenue Rankings

InterCure News

More News